INTRODUCTION

TEXAKIND contains Tranexamic acid which belongs to a group of medicines called anti-fibrinolytic agents, which is used to stop or reduce unwanted bleeding. It is used to prevent and treat bleeding due to a process that inhibits blood clotting in conditions such as heavy periods in women, gastrointestinal bleeding, haemorrhagic urinary disorders after having an operation on prostate gland or urinary tract, after having an operation on ear, nose or throat, after having heart, abdominal or gynecological surgery and bleeding after you have been treated with another medicine to break down blood clots.

Blood clots are formed by a protein called fibrin. There are enzymes in your body that break down fibrin which makes blood clots do not stay in place. This process is called "fibrinolysis". TEXAKIND is an anti-fibrinolytic which helps prevent fibrinolysis by stopping the fibrin from being broken down. This prevents the breakdown of blood clots and helps them to stay in place where they are needed (excessive bleeding during periods, or after surgery).

TEXAKIND should be only given by a doctor or nurse. Before using this medicine, tell your doctor if you have liver, kidney or heart problems, pregnant women and breastfeeding mothers. It is recommended to use in children above one year of age. The common side effects are diarrhoea and stomach pain.

USES OF TEXAKIND

• Prevent or reduce bleeding

HOW TEXAKIND WORKS

Blood clots are formed by a protein called fibrin. There are enzymes in your body that break down fibrin which makes blood clots do not stay in place. This process is called "fibrinolysis". TEXAKIND is an anti-fibrinolytic which helps prevent fibrinolysis by stopping the fibrin from being broken down. This prevents the breakdown of blood clots and helps them to stay in place where they are needed (excessive bleeding during periods, or after surgery).

DIRECTIONS FOR USE

This medicine should be only given by a doctor or nurse. Your healthcare provider will give you TEXAKIND by a slow injection into your vein.  

SIDE EFFECTS OF TEXAKIND

HOW TO MANAGE SIDE EFFECTS

Feeling or being sick:

Stick to simple normal meals and do not eat rich or spicy foods.

Diarrhoea:

Drink plenty of fluids to avoid dehydration. ORS should be used to prevent dehydration.

WARNING & PRECAUTIONS

INTERACTIONS

Inform your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription or the following,

• antifibrinolytic medicines (helps blood to clot)
• thrombolytic medicines (prevent blood clotting)
• oral contraceptives

SYNOPSIS

MORE INFORMATION

Store below 20-25°C and keep out of reach of children.

FAQs ABOUT TEXAKIND

Can TEXAKIND be injected into muscles?

No. It should be only given by a doctor or nurse by a slow injection into your vein.

Can TEXAKIND cause infertility?

It is taken only during the menstrual cycle and does not interfere with ovulation.

Does TEXAKIND safe in patients with kidney disease?

It is not recommended in patients with active kidney diseases unless necessary. Consult your doctor for advice.

REFERENCES

1. KD Tripathi MD. Drugs affecting blood and blood formation. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page – 628.

2. Zehnder JL. Drugs Used in Disorders of Coagulation. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page - 602.

3. Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics.12th ed. New York, New York: McGraw-Hill Medical; 2011. Page - 867-868.

4. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 1388-1389.

4. Stanislas Grassin-Delyle, Haleema Shakur-Still, Roberto Picetti, Catherine Gilliam and Harvey Pynn and Ian Roberts. Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial, September 30, 2020; [Accessed Dec 17, 2020] https://bjanaesthesia.org/article/S0007-0912(20)30682-6/fulltext   

5. Mercury Pharmaceuticals Limited, Bioindustria L.I.M., Electronic Medicines Compendium (EMC); [Revised July 2018] [Accessed Dec 17, 2020] https://www.medicines.org.uk/emc/files/pil.1220.pdf